1887

Abstract

A novel genetic approach for the control of virus replication was used for the design of a conditionally replicating human immunodeficiency virus (HIV) variant, HIV-rtTA. HIV-rtTA gene expression and virus replication are strictly dependent on the presence of a non-toxic effector molecule, doxycycline (dox), and thus can be turned on and off at will in a graded and reversible manner. The replication capacity, pathogenicity and genetic stability of this HIV-rtTA variant were evaluated in a humanized mouse model of haematopoiesis that harbours lymphoid and myeloid components of the human immune system (HIS). Infection of dox-fed BALB Rag/γc HIS (BRG-HIS) mice with HIV-rtTA led to the establishment of a productive infection without CD4 T-cell depletion. The virus did not show any sign of escape from dox control for up to 10 weeks after the onset of infection. No reversion towards a functional Tat–transactivating responsive (TAR) RNA element axis was observed, confirming the genetic stability of the HIV-rtTA variant . These results demonstrate the proof of concept that HIV-rtTA replicates efficiently . HIV-rtTA is a promising tool for fundamental research to study virus–host interactions in a controlled fashion.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.042796-0
2012-09-01
2020-01-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/9/2017.html?itemId=/content/journal/jgv/10.1099/vir.0.042796-0&mimeType=html&fmt=ahah

References

  1. An D. S., Poon B., Fang R. H. T., Weijer K., Blom B., Spits H., Chen I. S. Y., Uittenbogaart C. H.. ( 2007;). Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection. . Clin Vaccine Immunol 14:, 391–396. [CrossRef][PubMed]
    [Google Scholar]
  2. Baenziger S., Tussiwand R., Schlaepfer E., Mazzucchelli L., Heikenwalder M., Kurrer M. O., Behnke S., Frey J., Oxenius A.. & other authors ( 2006;). Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2−/−γ c−/− mice. . Proc Natl Acad Sci U S A 103:, 15951–15956. [CrossRef][PubMed]
    [Google Scholar]
  3. Becker P. D., Legrand N., van Geelen C. M., Noerder M., Huntington N. D., Lim A., Yasuda E., Diehl S. A., Scheeren F. A.. & other authors ( 2010;). Generation of human antigen-specific monoclonal IgM antibodies using vaccinated “human immune system” mice. . PLoS ONE 5:, e13137. [CrossRef][PubMed]
    [Google Scholar]
  4. Berges B. K., Rowan M. R.. ( 2011;). The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment. . Retrovirology 8:, 65. [CrossRef][PubMed]
    [Google Scholar]
  5. Berges B. K., Wheat W. H., Palmer B. E., Connick E., Akkina R.. ( 2006;). HIV-1 infection and CD4 T cell depletion in the humanized Rag2−/−γc−/− (RAG-hu) mouse model. . Retrovirology 3:, 76. [CrossRef][PubMed]
    [Google Scholar]
  6. Berkhout B., Marzio G., Verhoef K.. ( 2001;). Control over HIV-1 replication by an antibiotic; a novel vaccination strategy with a drug-dependent virus. . Virus Res 82:, 103–108. [CrossRef][PubMed]
    [Google Scholar]
  7. Boom R., Sol C. J., Salimans M. M., Jansen C. L., Wertheim-van Dillen P. M., van der Noordaa J.. ( 1990;). Rapid and simple method for purification of nucleic acids. . J Clin Microbiol 28:, 495–503.[PubMed]
    [Google Scholar]
  8. Centlivre M., Klaver B., Berkhout B., Das A. T.. ( 2008;). Functional analysis of the complex trans-activating response element RNA structure in simian immunodeficiency virus. . J Virol 82:, 9171–9178. [CrossRef][PubMed]
    [Google Scholar]
  9. Centlivre M., Zhou X., Pouw S. M., Weijer K., Kleibeuker W., Das A. T., Blom B., Seppen J., Berkhout B., Legrand N.. ( 2010;). Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo. . Gene Ther 17:, 14–25. [CrossRef][PubMed]
    [Google Scholar]
  10. Chen Q., Khoury M., Chen J.. ( 2009;). Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. . Proc Natl Acad Sci U S A 106:, 21783–21788. [CrossRef][PubMed]
    [Google Scholar]
  11. Das A. T., Verhoef K., Berkhout B.. ( 2004a;). A conditionally replicating virus as a novel approach toward an HIV vaccine. . Methods Enzymol 388:, 359–379. [CrossRef][PubMed]
    [Google Scholar]
  12. Das A. T., Zhou X., Vink M., Klaver B., Verhoef K., Marzio G., Berkhout B.. ( 2004b;). Viral evolution as a tool to improve the tetracycline-regulated gene expression system. . J Biol Chem 279:, 18776–18782. [CrossRef][PubMed]
    [Google Scholar]
  13. Das A. T., Harwig A., Vrolijk M. M., Berkhout B.. ( 2007;). The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription. . J Virol 81:, 7742–7748. [CrossRef][PubMed]
    [Google Scholar]
  14. Denton P. W., García J. V.. ( 2011;). Humanized mouse models of HIV infection. . AIDS Rev 13:, 135–148.[PubMed]
    [Google Scholar]
  15. Emiliani S., Van Lint C., Fischle W., Paras P. Jr, Ott M., Brady J., Verdin E.. ( 1996;). A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. . Proc Natl Acad Sci U S A 93:, 6377–6381. [CrossRef][PubMed]
    [Google Scholar]
  16. Gimeno R., Weijer K., Voordouw A., Uittenbogaart C. H., Legrand N., Alves N. L., Wijnands E., Blom B., Spits H.. ( 2004;). Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2−/− γc−/− mice: functional inactivation of p53 in developing T cells. . Blood 104:, 3886–3893. [CrossRef][PubMed]
    [Google Scholar]
  17. Gorantla S., Sneller H., Walters L., Sharp J. G., Pirruccello S. J., West J. T., Wood C., Dewhurst S., Gendelman H. E., Poluektova L.. ( 2007;). Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2−/−γc−/− mice. . J Virol 81:, 2700–2712. [CrossRef][PubMed]
    [Google Scholar]
  18. Gorantla S., Makarov E., Finke-Dwyer J., Gebhart C. L., Domm W., Dewhurst S., Gendelman H. E., Poluektova L. Y.. ( 2010;). CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. . J Immunol 184:, 7082–7091. [CrossRef][PubMed]
    [Google Scholar]
  19. Huntington N. D., Alves N. L., Legrand N., Lim A., Strick-Marchand H., Mention J. J., Plet A., Weijer K., Jacques Y.. & other authors ( 2011;). IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo. . Proc Natl Acad Sci U S A 108:, 6217–6222. [CrossRef][PubMed]
    [Google Scholar]
  20. Ince W. L., Zhang L., Jiang Q., Arrildt K., Su L., Swanstrom R.. ( 2010;). Evolution of the HIV-1 env gene in the Rag2−/− γC−/− humanized mouse model. . J Virol 84:, 2740–2752. [CrossRef][PubMed]
    [Google Scholar]
  21. Jeeninga R. E., Westerhout E. M., van Gerven M. L., Berkhout B.. ( 2008;). HIV-1 latency in actively dividing human T cell lines. . Retrovirology 5:, 37. [CrossRef][PubMed]
    [Google Scholar]
  22. Jiang Q., Zhang L., Wang R., Jeffrey J., Washburn M. L., Brouwer D., Barbour S., Kovalev G. I., Unutmaz D., Su L.. ( 2008;). FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2−/−γC−/− mice in vivo. . Blood 112:, 2858–2868. [CrossRef][PubMed]
    [Google Scholar]
  23. Kiselyeva Y., Ito Y., Lima R. G., Grivel J.-C., Das A. T., Berkhout B., Margolis L. B.. ( 2004;). Depletion of CD4 T lymphocytes in human lymphoid tissue infected ex vivo with doxycycline-dependent HIV-1. . Virology 328:, 1–6. [CrossRef][PubMed]
    [Google Scholar]
  24. Klausner R. D., Fauci A. S., Corey L., Nabel G. J., Gayle H., Berkley S., Haynes B. F., Baltimore D., Collins C.. & other authors ( 2003;). The need for a global HIV vaccine enterprise. . Science 300:, 2036–2039. [CrossRef][PubMed]
    [Google Scholar]
  25. Kleibeuker W., Zhou X., Centlivre M., Legrand N., Page M., Almond N., Berkhout B., Das A. T.. ( 2009;). A sensitive cell-based assay to measure the doxycycline concentration in biological samples. . Hum Gene Ther 20:, 524–530. [CrossRef][PubMed]
    [Google Scholar]
  26. Kubota S., Pomerantz R. J.. ( 1998;). A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins. . Oncogene 16:, 1851–1861. [CrossRef][PubMed]
    [Google Scholar]
  27. Legrand N., Huntington N. D., Nagasawa M., Bakker A. Q., Schotte R., Strick-Marchand H., de Geus S. J., Pouw S. M., Böhne M.. & other authors ( 2011;). Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. . Proc Natl Acad Sci U S A 108:, 13224–13229. [CrossRef][PubMed]
    [Google Scholar]
  28. Lepus C. M., Gibson T. F., Gerber S. A., Kawikova I., Szczepanik M., Hossain J., Ablamunits V., Kirkiles-Smith N., Herold K. C.. & other authors ( 2009;). Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/γc−/−, Balb/c-Rag1−/−γc−/−, and C.B-17-scid/bg immunodeficient mice. . Hum Immunol 70:, 790–802. [CrossRef][PubMed]
    [Google Scholar]
  29. Marzio G., Verhoef K., Vink M., Berkhout B.. ( 2001;). In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. . Proc Natl Acad Sci U S A 98:, 6342–6347. [CrossRef][PubMed]
    [Google Scholar]
  30. Marzio G., Vink M., Verhoef K., de Ronde A., Berkhout B.. ( 2002;). Efficient human immunodeficiency virus replication requires a fine-tuned level of transcription. . J Virol 76:, 3084–3088. [CrossRef][PubMed]
    [Google Scholar]
  31. O’Connell R. M., Balazs A. B., Rao D. S., Kivork C., Yang L., Baltimore D.. ( 2010;). Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. . PLoS ONE 5:, e12009. [CrossRef][PubMed]
    [Google Scholar]
  32. Pasternak A. O., Adema K. W., Bakker M., Jurriaans S., Berkhout B., Cornelissen M., Lukashov V. V.. ( 2008;). Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA. . J Clin Microbiol 46:, 2206–2211. [CrossRef][PubMed]
    [Google Scholar]
  33. Rongvaux A., Willinger T., Takizawa H., Rathinam C., Auerbach W., Murphy A. J., Valenzuela D. M., Yancopoulos G. D., Eynon E. E.. & other authors ( 2011;). Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. . Proc Natl Acad Sci U S A 108:, 2378–2383. [CrossRef][PubMed]
    [Google Scholar]
  34. Sango K., Joseph A., Patel M., Osiecki K., Dutta M., Goldstein H.. ( 2010;). Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2−/−γc−/− mice. . AIDS Res Hum Retroviruses 26:, 735–746. [CrossRef][PubMed]
    [Google Scholar]
  35. Sato K., Izumi T., Misawa N., Kobayashi T., Yamashita Y., Ohmichi M., Ito M., Takaori-Kondo A., Koyanagi Y.. ( 2010;). Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice. . J Virol 84:, 9546–9556. [CrossRef][PubMed]
    [Google Scholar]
  36. Strowig T., Rongvaux A., Rathinam C., Takizawa H., Borsotti C., Philbrick W., Eynon E. E., Manz M. G., Flavell R. A.. ( 2011;). Transgenic expression of human signal regulatory protein alpha in Rag2−/−γc−/− mice improves engraftment of human hematopoietic cells in humanized mice. . Proc Natl Acad Sci U S A 108:, 13218–13223. [CrossRef][PubMed]
    [Google Scholar]
  37. ter Brake O., Legrand N., von Eije K. J., Centlivre M., Spits H., Weijer K., Blom B., Berkhout B.. ( 2009;). Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2−/−γc−/−) mouse model. . Gene Ther 16:, 148–153. [CrossRef][PubMed]
    [Google Scholar]
  38. Traggiai E., Chicha L., Mazzucchelli L., Bronz L., Piffaretti J. C., Lanzavecchia A., Manz M. G.. ( 2004;). Development of a human adaptive immune system in cord blood cell-transplanted mice. . Science 304:, 104–107. [CrossRef][PubMed]
    [Google Scholar]
  39. van der Kuyl A. C., Kozaczynska K., Ariën K. K., Gali Y., Balázs V. R., Dekker S. J., Zorgdrager F., Vanham G., Berkhout B., Cornelissen M.. ( 2010;). Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness. . Retrovirology 7:, 60. [CrossRef][PubMed]
    [Google Scholar]
  40. van Lent A. U., Dontje W., Nagasawa M., Siamari R., Bakker A. Q., Pouw S. M., Maijoor K. A., Weijer K., Cornelissen J. J.. & other authors ( 2009;). IL-7 enhances thymic human T cell development in “human immune system” Rag2−/−IL-2Rγc−/− mice without affecting peripheral T cell homeostasis. . J Immunol 183:, 7645–7655. [CrossRef][PubMed]
    [Google Scholar]
  41. van Lent A. U., Centlivre M., Nagasawa M., Karrich J. J., Pouw S. M., Weijer K., Spits H., Blom B., Legrand N.. ( 2010;). In vivo modulation of gene expression by lentiviral transduction in “human immune system” Rag2−/−γc−/− mice. . Methods Mol Biol 595:, 87–115. [CrossRef][PubMed]
    [Google Scholar]
  42. Verhoef K., Marzio G., Hillen W., Bujard H., Berkhout B.. ( 2001;). Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. . J Virol 75:, 979–987. [CrossRef][PubMed]
    [Google Scholar]
  43. Vuyyuru R., Patton J., Manser T.. ( 2011;). Human immune system mice: current potential and limitations for translational research on human antibody responses. . Immunol Res 51:, 257–266. [CrossRef][PubMed]
    [Google Scholar]
  44. Weijer K., Uittenbogaart C. H., Voordouw A., Couwenberg F., Seppen J., Blom B., Vyth-Dreese F. A., Spits H.. ( 2002;). Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo. . Blood 99:, 2752–2759. [CrossRef][PubMed]
    [Google Scholar]
  45. Willinger T., Rongvaux A., Strowig T., Manz M. G., Flavell R. A.. ( 2011;). Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. . Trends Immunol 32:, 321–327. [CrossRef][PubMed]
    [Google Scholar]
  46. Yamada T., Iwamoto A.. ( 2000;). Comparison of proviral accessory genes between long-term nonprogressors and progressors of human immunodeficiency virus type 1 infection. . Arch Virol 145:, 1021–1027. [CrossRef][PubMed]
    [Google Scholar]
  47. Zhang L., Kovalev G. I., Su L.. ( 2007;). HIV-1 infection and pathogenesis in a novel humanized mouse model. . Blood 109:, 2978–2981.[PubMed]
    [Google Scholar]
  48. Zhang L., Jiang Q., Li G., Jeffrey J., Kovalev G. I., Su L.. ( 2011;). Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2−/−γ C−/− mice in vivo. . Blood 117:, 6184–6192. [CrossRef][PubMed]
    [Google Scholar]
  49. Zhou X., Vink M., Berkhout B., Das A. T.. ( 2006a;). Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control. . Retrovirology 3:, 82. [CrossRef][PubMed]
    [Google Scholar]
  50. Zhou X., Vink M., Klaver B., Berkhout B., Das A. T.. ( 2006b;). Optimization of the Tet-On system for regulated gene expression through viral evolution. . Gene Ther 13:, 1382–1390. [CrossRef][PubMed]
    [Google Scholar]
  51. Zhou X., Vink M., Klaver B., Verhoef K., Marzio G., Das A. T., Berkhout B.. ( 2006c;). The genetic stability of a conditional live HIV-1 variant can be improved by mutations in the Tet-On regulatory system that restrain evolution. . J Biol Chem 281:, 17084–17091. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.042796-0
Loading
/content/journal/jgv/10.1099/vir.0.042796-0
Loading

Data & Media loading...

Supplements

Supplementary material 

PDF

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error